Shattuck Labs (STTK) Operating Leases (2022 - 2026)
Shattuck Labs (STTK) posted quarterly Operating Leases of $2.0 million for Q1 2026, down 10.11% year-over-year from $2.3 million in Q1 2025, and up 28.6% quarter-over-quarter from $1.6 million in Q4 2025.
Shattuck Labs (STTK) Operating Leases (2022 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Operating Leases for 5 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 10.11% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (down 10.11% YoY), while the FY2025 annual figure was $1.6 million, down 36.79% from the prior year.
- Operating Leases rose to $2.0 million in Q1 2026 per STTK's latest filing, from $1.6 million in the prior quarter.
- Across five years, Operating Leases topped out at $5.3 million in Q1 2022 and bottomed at $1.6 million in Q4 2025.
- Historically, Operating Leases has averaged $3.2 million across 5 years, with a median of $3.2 million in 2024.
- Annual changes were most pronounced in 2023 — Operating Leases changed 0.0% — and 2024, when it tumbled 40.36%.
- Shattuck Labs' Operating Leases stood at $4.2 million in 2022, then changed by 0.0% to $4.2 million in 2023, then tumbled by 40.36% to $2.5 million in 2024, then plunged by 36.79% to $1.6 million in 2025, then advanced by 28.6% to $2.0 million in 2026.
- Business Quant data shows STTK's Operating Leases at $2.0 million in Q1 2026, $1.6 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.80 Mn |
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 2.51 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | 2.97 Mn |
| Mar 31, 2024 | 3.19 Mn |
| Dec 31, 2023 | 4.20 Mn |
| Sep 30, 2023 | 3.62 Mn |
| Jun 30, 2023 | 3.82 Mn |
| Mar 31, 2023 | 4.01 Mn |
| Dec 31, 2022 | 4.20 Mn |
| Sep 30, 2022 | 4.39 Mn |
| Jun 30, 2022 | 4.57 Mn |
| Mar 31, 2022 | 5.35 Mn |